Although the primary endpoint was not significant, notable improvements in pain were observed at different time points.
News
Those who developed vascular parkinsonism had a greater risk if they had microbleeds and low gray matter volume.
Levels of GABA increase during adolescence, helping to lessen the frequency and severity of tics.
Causes other than asphyxia account for most cases of cerebral palsy in near-term infants.
If approved, Nuplazid will be the first drug approved to treat psychosis in Parkinson’s disease.
More severe asthma equated to a greater risk of Parkinson’s disease later in life.
Reduced risk was only seen in patients actively taking glitazones.
The findings echo results observed in Parkinson’s patients taking L-DOPA therapy.
Antipsychotics significantly increase mortality rates for patients with Parkinson’s disease.
Injected apomorphine works faster than oral levodopa to treat morning akinesia in Parkinson’s disease.
Parkinson’s disease may be associated with a higher risk of most cancers.
Parkinson’s disease patients who took inhaled levodopa experienced fewer “off” hours per day.
With a 77% risk of heritability, tic disorders are among the most heritable neuropsychiatric disorders.
The device was effective on its own in most patients with essential tremor.
Although the risk is low, researchers are calling their findings substantial.
The reaction promotes a sustained state of inflammation which damages the brain.
Despite long-term pain relief in Parkinson’s, STN DBS does not seem to prevent new pain from forming.
Despite positive results in a mouse model, creatine was not effective in adults with Parkinson’s.
The test may also have potential to be used to track treatment effectiveness.
The results of the placebo effect were even evident on MRI scans.
Compared to 130 Hz DBS, 60 Hz was more effective at reducing aspiration and freezing of gait.
The prototype has only been tested on 27 subjects, but a larger study is planned.
Rytary is meant to reduce “on” and “off” periods of Parkinson’s symptoms.
Exercise was not effective for patients with more advanced cases of Parkinson’s.
Sergey Brin, co-founder of Google, which acquired Lift Labs, has donated more than $50 million to Parkinson’s research.
A review of adverse drug events showed a strong tendency for impulsive behaviors in those taking dopamine agonists, including Parkinson’s patients.
